Paper Details
- Home
- Paper Details
Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component.
Author: CarranzaPaula, CorradinGiampietro, KowarikMichael, SteffenMichael, WackerMichael, WetterMichael
Original Abstract of the Article :
State-of-the-art production technologies for conjugate vaccines are complex, multi-step processes. An alternative approach to produce glycoconjugates is based on the bacterial N-linked protein glycosylation system first described in Campylobacter jejuni. The C. jejuni N-glycosylation system has been...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1007/s10719-012-9451-9
データ提供:米国国立医学図書館(NLM)
Engineering a New Vaccine: Targeting Typhoid Fever
Typhoid fever, a serious bacterial infection, continues to be a threat to global health. This study explores a novel approach to developing a typhoid vaccine, utilizing the bacterial N-linked protein glycosylation system to engineer a conjugate vaccine. The researchers investigate the potential of using the O antigen of Escherichia coli O121, a polysaccharide that resembles the Vi antigen of Salmonella enterica serovar Typhi, as a vaccine component.
The researchers successfully engineered a mutant strain of E. coli O121 that produces an O polysaccharide reactive with antibodies against the Vi antigen. They demonstrate that this polysaccharide can be transferred to acceptor proteins using the bacterial N-linked protein glycosylation system, paving the way for the development of a novel conjugate vaccine against typhoid fever.
A Novel Approach to Vaccine Development
This study offers a promising new strategy for developing a typhoid vaccine. The researchers' innovative approach utilizes the bacterial N-linked protein glycosylation system to engineer a conjugate vaccine that may offer improved efficacy and safety.
Fighting Typhoid Fever with Innovation
The development of a novel typhoid vaccine is a crucial step toward combating this serious infectious disease. The researchers' innovative approach to vaccine engineering holds promise for improving the effectiveness of existing vaccines and potentially developing new vaccines that can provide long-lasting protection against typhoid fever.
Dr.Camel's Conclusion
This study highlights the exciting potential of bioengineering in the development of new vaccines. The researchers' innovative approach to vaccine engineering offers hope for improved protection against typhoid fever, a disease that continues to affect millions worldwide. It's a reminder that the journey toward a healthier world is an ongoing quest for innovation and advancement.
Date :
- Date Completed 2013-12-23
- Date Revised 2021-10-21
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.